KPMA demanded for smooth supply of prescription drugs to member companies.

Published: 2000-08-15 09:39:00

Updated: 2000-08-15 09:39:00

The KPMA urged its member companies to manufacture and supply sufficient stocks of prescriptions drugs for satisfying ever increasing market demands resulted from implementation of the new medical reform program.

The drug industry promised to expand their supplies not only to their existing cu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK